DK2986731T3 - Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner - Google Patents

Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner Download PDF

Info

Publication number
DK2986731T3
DK2986731T3 DK14724974.2T DK14724974T DK2986731T3 DK 2986731 T3 DK2986731 T3 DK 2986731T3 DK 14724974 T DK14724974 T DK 14724974T DK 2986731 T3 DK2986731 T3 DK 2986731T3
Authority
DK
Denmark
Prior art keywords
expression
biologically active
elevated levels
synthesis system
active proteins
Prior art date
Application number
DK14724974.2T
Other languages
Danish (da)
English (en)
Inventor
Alice Yam
Christopher D Thanos
Dan Groff
Patrick Rivers
Original Assignee
Sutro Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutro Biopharma Inc filed Critical Sutro Biopharma Inc
Application granted granted Critical
Publication of DK2986731T3 publication Critical patent/DK2986731T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK14724974.2T 2013-04-19 2014-04-18 Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner DK2986731T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361813914P 2013-04-19 2013-04-19
US201461937069P 2014-02-07 2014-02-07
PCT/US2014/034643 WO2014172631A2 (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression

Publications (1)

Publication Number Publication Date
DK2986731T3 true DK2986731T3 (da) 2022-08-01

Family

ID=50733442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14724974.2T DK2986731T3 (da) 2013-04-19 2014-04-18 Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner

Country Status (13)

Country Link
US (3) US10190145B2 (enExample)
EP (1) EP2986731B1 (enExample)
JP (2) JP6463732B2 (enExample)
KR (1) KR102289258B1 (enExample)
CN (1) CN105283556B (enExample)
AU (1) AU2014253785B2 (enExample)
CA (1) CA2909516C (enExample)
DK (1) DK2986731T3 (enExample)
ES (1) ES2922358T3 (enExample)
HU (1) HUE059565T2 (enExample)
IL (1) IL242148B (enExample)
SG (2) SG10202108497TA (enExample)
WO (1) WO2014172631A2 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2986731T3 (da) 2013-04-19 2022-08-01 Sutro Biopharma Inc Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner
WO2016004024A1 (en) 2014-07-02 2016-01-07 Sutro Biopharma, Inc. High growth capacity auxotrophic escherichia coli and methods of use
RU2739500C2 (ru) * 2014-11-05 2020-12-25 Дженентек, Инк. Способы получения двуцепочечных белков в бактериях
CN108064308B (zh) 2014-11-05 2023-06-09 豪夫迈·罗氏有限公司 细菌中产生双链蛋白的方法
WO2016100889A1 (en) * 2014-12-19 2016-06-23 Sutro Biopharma, Inc. Codon optimization for titer and fidelity improvement
HK1245154A1 (zh) 2014-12-30 2018-08-24 细胞基因公司 抗cd47抗体及其用途
HRP20192217T1 (hr) * 2015-03-06 2020-02-21 F. Hoffmann - La Roche Ag ULTRA-PROČIŠĆENI DsbA I DsbC TE POSTUPCI NJIHOVE IZRADE I UPORABE
US20170029798A1 (en) * 2015-07-27 2017-02-02 Cellivery Therapeutics, Inc. Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
CN108473558A (zh) * 2015-08-20 2018-08-31 豪夫迈·罗氏有限公司 Fkpa的纯化及其用于生产重组多肽的用途
CN105198983B (zh) * 2015-09-11 2018-11-06 中国石油大学(华东) 一种利于七次跨膜蛋白ccr5功能性表达的方法
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
CN106399352B (zh) * 2016-11-09 2020-04-17 华东理工大学 调节目标蛋白表达的折叠因子及其应用
US11136586B2 (en) 2016-12-30 2021-10-05 Ntxbio, Llc Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
IL267709B2 (en) 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
US12227778B2 (en) 2016-12-30 2025-02-18 Nature's Toolbox, Inc. Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
WO2019014398A1 (en) 2017-07-11 2019-01-17 Actym Therapeutics, Inc. MODIFIED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
TWI821192B (zh) 2017-07-11 2023-11-11 美商新索思股份有限公司 非天然核苷酸之導入及其方法
IL321812A (en) 2017-08-03 2025-08-01 Synthorx Inc Cytokine complexes for the treatment of autoimmune diseases
EP3665188A4 (en) * 2017-08-11 2021-07-21 Synvitrobio, Inc. IMPROVED IN VITRO TRANSLATION / TRANSLATION SYSTEM (TXTL) AND ITS USES
WO2019127469A1 (zh) * 2017-12-29 2019-07-04 康码(上海)生物科技有限公司 一种高效的能源再生体系(bes)、试剂盒及其制备方法
AU2019224159B2 (en) 2018-02-26 2025-05-29 Sanofi IL-15 conjugates and uses thereof
CA3176812A1 (en) 2018-07-11 2020-01-16 Actym Therapeutics, Inc. Engineered immunostimulatory bacterial strains and uses thereof
CN113260626B (zh) 2018-11-05 2024-09-13 豪夫迈·罗氏有限公司 在原核宿主细胞中产生双链蛋白质的方法
TW202031284A (zh) 2018-11-08 2020-09-01 美商新索思股份有限公司 介白素10結合物及其用途
IL282875B2 (en) * 2018-11-08 2026-05-01 Sutro Biopharma Inc E. coli strains with oxygenated cytoplasm
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
MA54952A (fr) 2019-02-06 2022-05-11 Synthorx Inc Conjugués d'il-2 et méthodes d'utilisation de ceux-ci
KR20220004959A (ko) 2019-02-27 2022-01-12 액팀 테라퓨틱스, 인코퍼레이티드 종양, 종양-상주 면역 세포, 및 종양 미세환경을 콜로니화하기 위해 조작된 면역자극성 박테리아
EP4013454A1 (en) 2019-08-15 2022-06-22 Synthorx, Inc. Immuno oncology combination therapies with il-2 conjugates
WO2021050554A1 (en) 2019-09-10 2021-03-18 Synthorx, Inc. Il-2 conjugates and methods of use to treat autoimmune diseases
JP2022554272A (ja) 2019-11-04 2022-12-28 シンソークス, インコーポレイテッド インターロイキン10コンジュゲートおよびその使用
US12679875B2 (en) * 2019-11-08 2026-07-14 Korea Institute Of Ocean Science & Technology Human epidermal growth factor-TF fusion protein and use thereof
EP4114931A4 (en) * 2020-03-05 2024-05-01 Curie Co. Inc. METHODS FOR CELL PROTEIN EXPRESSION OF MATURE POLYPEPTIDES DERIVED FROM ZYMOGENS AND PROPROTEINS
EP4142711A1 (en) * 2020-04-29 2023-03-08 Willow Biosciences Inc. Compositions and methods for enhancing recombinant biosynthesis of cannabinoids
WO2021263026A1 (en) 2020-06-25 2021-12-30 Synthorx, Inc. Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies
KR20220000028U (ko) 2020-06-29 2022-01-05 채인자 농작물용 농약 간편 분무장치
EP4211156A1 (en) * 2020-09-14 2023-07-19 Sutro Biopharma, Inc. Method for large scale production of antibodies using a cell-free protein synthesis system
EP4225376A1 (en) 2020-10-09 2023-08-16 Synthorx, Inc. Immuno oncology combination therapy with il-2 conjugates and pembrolizumab
IL301612A (en) 2020-10-09 2023-05-01 Synthorx Inc Immuno oncology therapies with il-2 conjugates
WO2022104367A1 (en) 2020-11-12 2022-05-19 Northwestern University Cell-free expression of antibodies, antigen-binding fragments thereof, and antibody derivatives
TW202302148A (zh) 2021-02-12 2023-01-16 美商欣爍克斯公司 使用il-2接合物和抗pd-1抗體或其抗原結合片段的肺癌組合療法
WO2022174101A1 (en) 2021-02-12 2022-08-18 Synthorx, Inc. Skin cancer combination therapy with il-2 conjugates and cemiplimab
WO2022256534A1 (en) 2021-06-03 2022-12-08 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
EP4452327A1 (en) 2021-12-20 2024-10-30 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab
CN116555061B (zh) * 2022-01-28 2026-07-17 北京师范大学 一种酿酒酵母突变体及其在制备酒精中的应用
US12163190B2 (en) * 2022-06-17 2024-12-10 Insitro, Inc. In situ sequencing of RNA transcripts with non-uniform 5 prime ends
CN115028691B (zh) * 2022-06-29 2024-09-10 青岛硕景生物科技有限公司 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用
WO2024136899A1 (en) 2022-12-21 2024-06-27 Synthorx, Inc. Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies
CN121263208A (zh) 2023-03-20 2026-01-02 新索思股份有限公司 使用il-2 peg缀合物的癌症疗法
CN116925196B (zh) * 2023-06-08 2025-04-18 齐鲁工业大学(山东省科学院) 小分子热休克蛋白rsp_1572在提高宿主菌环境耐受性中的应用
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
CN118048325B (zh) * 2024-04-16 2024-07-16 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法
WO2025218039A1 (zh) * 2024-04-16 2025-10-23 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法
WO2025240255A1 (en) * 2024-05-11 2025-11-20 Biodiscovery, Llc Systems and methods of cell-free protein expression
WO2026136953A2 (en) 2024-12-20 2026-06-25 Sutro Biopharma, Inc. High cell density fed-batch fermentation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145694A1 (de) 2001-09-17 2003-04-03 Roche Diagnostics Gmbh Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung
US20060134739A1 (en) * 2003-03-11 2006-06-22 Chatterjee Deb K Synthesis of proteins by cell-free protein expression
JP2005253432A (ja) * 2004-03-15 2005-09-22 Sekisui Chem Co Ltd タンパク質の生産方法、並びにそれに使用するための組成物、試薬及びキット
JP4561243B2 (ja) * 2004-08-27 2010-10-13 株式会社豊田中央研究所 無細胞タンパク質合成系のための媒体
DK2035554T3 (da) * 2006-06-29 2013-06-17 Univ Leland Stanford Junior Celle-fri syntese af proteiner indeholdende ikke-naturlige aminosyrer
CA2673765A1 (en) * 2007-01-18 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
EP2379578A4 (en) 2009-01-12 2012-05-02 Sutro Biopharma Inc DOUBLE-LOADING SYSTEM FOR THE SELECTIVE INTRODUCTION OF NON-NITIVE AMINO ACIDS IN PROTEINS DUE TO AN IN VITRO-SYNTHESIS PROCESS
US20110136169A1 (en) * 2009-11-20 2011-06-09 Rutgers, The State University Of New Jersey Expression system compositions and methods
CN102732548A (zh) 2012-05-16 2012-10-17 中国农业大学 一种表达蛇毒激肽原酶的高效麦胚无细胞蛋白合成系统的建立及应用
WO2014058830A1 (en) * 2012-10-12 2014-04-17 Sutro Biopharma, Inc. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
DK2986731T3 (da) 2013-04-19 2022-08-01 Sutro Biopharma Inc Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner

Also Published As

Publication number Publication date
KR20160002913A (ko) 2016-01-08
JP2018157837A (ja) 2018-10-11
ES2922358T3 (es) 2022-09-13
US20190161781A1 (en) 2019-05-30
CN105283556B (zh) 2020-07-14
US20210054429A1 (en) 2021-02-25
AU2014253785B2 (en) 2018-07-19
SG11201508642WA (en) 2015-11-27
KR102289258B1 (ko) 2021-08-11
WO2014172631A4 (en) 2015-02-19
HUE059565T2 (hu) 2022-11-28
US10190145B2 (en) 2019-01-29
US20140315245A1 (en) 2014-10-23
US10774354B2 (en) 2020-09-15
IL242148B (en) 2019-03-31
JP2016518833A (ja) 2016-06-30
CA2909516A1 (en) 2014-10-23
WO2014172631A3 (en) 2014-12-18
SG10202108497TA (en) 2021-09-29
EP2986731B1 (en) 2022-05-18
JP6463732B2 (ja) 2019-02-06
CA2909516C (en) 2023-03-07
WO2014172631A2 (en) 2014-10-23
CN105283556A (zh) 2016-01-27
EP2986731A2 (en) 2016-02-24
HK1220993A1 (en) 2017-05-19
AU2014253785A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
IL242148B (en) Expression of biologically active proteins in a cell-free bacterial expression system containing high levels of external chaperones
IL229803B (en) Mammalian cell culture
BR112015030946A2 (pt) composição compreendendo uma célula ß pancreática não-nativa, método de diferenciação de células progenitoras em células ß pancreáticas in vitro e uso de uma célula ß pancreática não-nativa
DK3351620T3 (da) Metabolsk optimeret cellekultur
EP2855736A4 (en) ELECTROLYTE AND ENERGY SYSTEM
DK2780022T4 (da) Farmaceutiske præparater af humane rpe-celler og anvendelser deraf
DK2705143T3 (da) Protein-induceret pluripotent celleteknologi og anvendelse deraf
GB2561496A (en) Devices and methods for simulating a function of a liver tissue
PL3205230T5 (pl) Lekki modularny system mocowania kieszeni i sposób
EP2780952A4 (en) INTELLIGENT PV CELLS AND PV MODULES
IL240252B (en) Solid substrates for promoting cell and tissue growth
HRP20200893T4 (hr) Pripravci stanične kulture s antioksidansima i postupci proizvodnje polipeptida
SG10201606745XA (en) Therapeutics using adipose cells and cell secretions
EP2895594A4 (en) ELECTROSYNTHETIC MICROBIAL CELLS
HRP20181310T1 (hr) Novi heterociklički derivati i njihova uporaba
DK2744456T3 (da) Forbedringer ved eller i forbindelse med proteser og ortoser
EP2555314A4 (en) PHOTOELECTROCHEMICAL CELL AND ENERGY SYSTEM THEREWITH
CO6870031A2 (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
EP2879794A4 (en) CELL CULTURE
EP3066193C0 (en) CELL CULTURE PROCESS
CO6870003A2 (es) Vacunas bovinas y métodos
UY34124A (es) Cerramiento y método para conformarlo
EP2753346A4 (en) CERAMIDASE AND CELL DIFFERENTIATION
BR112014002624A2 (pt) microorganismo recombinante e cultura de microorganismo recombinante
HRP20170203T1 (hr) Prenaponski bipolarni baterijski pulser i metoda